214 related articles for article (PubMed ID: 34937742)
21. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells.
Fisher JP; Yan M; Heuijerjans J; Carter L; Abolhassani A; Frosch J; Wallace R; Flutter B; Capsomidis A; Hubank M; Klein N; Callard R; Gustafsson K; Anderson J
Clin Cancer Res; 2014 Nov; 20(22):5720-32. PubMed ID: 24893631
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.
Negash M; Tsegaye A; Wassie L; Howe R
BMC Infect Dis; 2018 Sep; 18(1):464. PubMed ID: 30219039
[TBL] [Abstract][Full Text] [Related]
23. Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells.
Sacchi A; Tumino N; Sabatini A; Cimini E; Casetti R; Bordoni V; Grassi G; Agrati C
Front Immunol; 2018; 9():1271. PubMed ID: 29928279
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.
Devaud C; Bilhere E; Loizon S; Pitard V; Behr C; Moreau JF; Dechanet-Merville J; Capone M
Cancer Res; 2009 May; 69(9):3971-8. PubMed ID: 19383918
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma-infiltrating γδ T cells are functionally defected and allogenic Vδ2
He W; Hu Y; Chen D; Li Y; Ye D; Zhao Q; Lin L; Shi X; Lu L; Yin Z; He X; Gao Y; Wu Y
Clin Transl Med; 2022 Apr; 12(4):e800. PubMed ID: 35390227
[TBL] [Abstract][Full Text] [Related]
26. Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.
Nguyen S; Chevalier MF; Benmerzoug S; Cesson V; Schneider AK; Rodrigues-Dias SC; Dartiguenave F; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002184
[No Abstract] [Full Text] [Related]
27. mTOR inhibition potentiates cytotoxicity of Vγ4 γδ T cells via up-regulating NKG2D and TNF-α.
Cao G; Wang Q; Li G; Meng Z; Liu H; Tong J; Huang W; Liu Z; Jia Y; Wei J; Chi H; Yang H; Zhao L; Wu Z; Hao J; Yin Z
J Leukoc Biol; 2016 Nov; 100(5):1181-1189. PubMed ID: 27256566
[TBL] [Abstract][Full Text] [Related]
28. Vitamin C promotes the proliferation and effector functions of human γδ T cells.
Kouakanou L; Xu Y; Peters C; He J; Wu Y; Yin Z; Kabelitz D
Cell Mol Immunol; 2020 May; 17(5):462-473. PubMed ID: 31171862
[TBL] [Abstract][Full Text] [Related]
29. Possible Application of Ascites-infiltrating Gamma-delta T Cells for Adoptive Immunotherapy.
Abe Y; Kobayashi H; Akizawa Y; Ishitani K; Hashimoto K; Matsui H
Anticancer Res; 2018 Jul; 38(7):4327-4331. PubMed ID: 29970569
[TBL] [Abstract][Full Text] [Related]
30. γδ T cells in hepatocellular carcinoma patients present cytotoxic activity but are reduced in potency due to IL-2 and IL-21 pathways.
Jiang H; Yang Z; Song Z; Green M; Song H; Shao Q
Int Immunopharmacol; 2019 May; 70():167-173. PubMed ID: 30802679
[TBL] [Abstract][Full Text] [Related]
31. Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.
Landmeier S; Altvater B; Pscherer S; Juergens H; Varnholt L; Hansmeier A; Bollard CM; Moosmann A; Bisping G; Rossig C
J Immunother; 2009 Apr; 32(3):310-21. PubMed ID: 19242369
[TBL] [Abstract][Full Text] [Related]
32. Transient 40 °C-shock potentiates cytotoxic responses of Vδ2
Lin L; Chen Y; Chen D; Shu J; Hu Y; Yin Z; Wu Y
Cancer Immunol Immunother; 2022 Oct; 71(10):2391-2404. PubMed ID: 35195762
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals.
Ryan PL; Sumaria N; Holland CJ; Bradford CM; Izotova N; Grandjean CL; Jawad AS; Bergmeier LA; Pennington DJ
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14378-14383. PubMed ID: 27911793
[TBL] [Abstract][Full Text] [Related]
34. Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations.
Nerdal PT; Peters C; Oberg HH; Zlatev H; Lettau M; Quabius ES; Sousa S; Gonnermann D; Auriola S; Olive D; Määttä J; Janssen O; Kabelitz D
J Immunol; 2016 Oct; 197(8):3059-3068. PubMed ID: 27619996
[TBL] [Abstract][Full Text] [Related]
35. The BLT Humanized Mouse Model as a Tool for Studying Human Gamma Delta T Cell-HIV Interactions
Biradar S; Agarwal Y; Lotze MT; Bility MT; Mailliard RB
Front Immunol; 2022; 13():881607. PubMed ID: 35669780
[TBL] [Abstract][Full Text] [Related]
36. In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.
Hodgins NO; Al-Jamal WT; Wang JT; Parente-Pereira AC; Liu M; Maher J; Al-Jamal KT
J Control Release; 2016 Nov; 241():229-241. PubMed ID: 27664328
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.
Alejenef A; Pachnio A; Halawi M; Christmas SE; Moss PA; Khan N
Clin Exp Immunol; 2014 Jun; 176(3):418-28. PubMed ID: 24547915
[TBL] [Abstract][Full Text] [Related]
38. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.
Wistuba-Hamprecht K; Martens A; Haehnel K; Geukes Foppen M; Yuan J; Postow MA; Wong P; Romano E; Khammari A; Dreno B; Capone M; Ascierto PA; Demuth I; Steinhagen-Thiessen E; Larbi A; Schilling B; Schadendorf D; Wolchok JD; Blank CU; Pawelec G; Garbe C; Weide B
Eur J Cancer; 2016 Sep; 64():116-26. PubMed ID: 27400322
[TBL] [Abstract][Full Text] [Related]
39. Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations.
Hunter S; Willcox CR; Davey MS; Kasatskaya SA; Jeffery HC; Chudakov DM; Oo YH; Willcox BE
J Hepatol; 2018 Sep; 69(3):654-665. PubMed ID: 29758330
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of Human Peripheral Blood γδ T Cells Expanded With Zoledronate.
Kim M; Kim H; Han M; Hwang HJ; Kim H; Im HJ; Kim N; Koh KN
Anticancer Res; 2021 Dec; 41(12):6031-6038. PubMed ID: 34848457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
